experimental cancer research 2006 ... - fmi.ch · n engl j med 353, 1768-1771, 2005. microrna and...
TRANSCRIPT
1
EXPERIMENTAL CANCERRESEARCH 2006
Posttranscriptional Mechanisms inOncogenesis
21.4.2006
Christoph MoroniInstitut für Med. Mikrobiologie
Universität Basel
PROTO-ONKOGENE
SUPPRESSOR-GENE
VERLUST
AKTIVIERUNG
KREBS
N = Synthesis - Degradation
NmRNA = Transcription - RNA decay
cis-ElementsRNA-binding ProteinsRNases
Promotor/ EnhancerTranscription FactorsPol-II
2
3
4
(W. Filipowicz)Sherr, Nat. Rev. MCB, 2001
5
Arnold J. Levine et al. Genes Dev. 2006; 20: 267-275
Figure 2
Primary cells Transformed cells
hTERT Oncogenic ras
p53
pRB PP2A
Viral LT sT
The tumor-suppressive functions of the human INK4A locusVoorhoeve and AgamiCancer Cell, 4, 311. 2003
A MicroRNA signature associated with prognosis and progressionin chronic lymphocytic leukemia.N Engl J Med 353, 1793-1801, 2005.
MicroRNA profiling reveals distinct signatures in B cell chroniclymphocytic leukemias.Proc Natl Acad Sci U S A 101, 11755-11760, 2004.
Human microRNA genes are frequently located at fragile sites andgenomic regions involved in cancers.Proc Natl Acad Sci U S A 101, 2999-3004, 2004.
MicroRNAs as oncogenes and tumor suppressors.N Engl J Med 353, 1768-1771, 2005.
microRNA and Cancer (I)
miR-15 and miR-16 induce apoptosis by targeting BCL2.Proc Natl Acad Sci U S A 102, 13944-13949, 2005.
RAS is regulated by the let-7 microRNA family. Cell 120, 635-647, 2005.
MicroRNA expression profiles classify human cancers. Nature 435, 834-838, 2005.
A genetic screen implicates miRNA-372 and miRNA-373 asoncogenes in testicular germ cell tumors. Cell 124, 1169-1181, 2006
microRNA and Cancer (II)
Cell, 124, 1169, 2006 Cell, 124, 1169, 2006
6
Cell, 124, 1169, 2006
Cell, 124, 1169, 2006
Cell, 124, 1169, 2006
Cell, 124, 1169, 2006
Cell, 124, 1169, 2006
Summary and Conclusion
• miR372 and miR 373 are regulators ofthe oncogenic stress response pathway
• Overcome ras-induced senescence• Expressed in p53-wt seminomas• Acts in part via LATS2 (a tumor
suppressor gene